Roles of galectin-7 and S100A9 in cervical squamous carcinoma: Clinicopathological and in vitro evidence (Q39302180)

10 September 2017

title

Roles of galectin-7 and S100A9 in cervical squamous carcinoma: Clinicopathological and in vitro evidence (English)

1 reference

10 September 2017

Hong Zhu

1

1 reference

10 September 2017

Tian-Cong Wu

2

1 reference

10 September 2017

Wei-Qiong Chen

3

1 reference

10 September 2017

Li-Jun Zhou

4

1 reference

10 September 2017

Yue Wu

5

1 reference

10 September 2017

Liang Zeng

6

1 reference

10 September 2017

Hai-Ping Pei

7

1 reference

10 September 2017

language of work or name

English

0 references

publication date

28 August 2012

1 reference

International Journal of Cancer

10 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

10 September 2017

volume

132

1 reference

10 September 2017

issue

5

1 reference

10 September 2017

page(s)

1051-1059

1 reference

Analysis of antibody response to HPV 16 and HPV 18 antigens in Tunisian patients

10 September 2017

cites work

1 reference

Epigenetics of cervical cancer. An overview and therapeutic perspectives

21 January 2018

1 reference

Management of metastatic cervical cancer: review of the literature

21 January 2018

1 reference

The carcinogenic role of oncogenic HPV and p53 gene mutation in cervical adenocarcinomas

21 January 2018

1 reference

Galectins as modulators of tumour progression

21 January 2018

1 reference

Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis.

21 January 2018

1 reference

21 January 2018

1 reference

Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype

21 January 2018

1 reference

Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells

21 January 2018

1 reference

Suppression of tumor growth by galectin-7 gene transfer

21 January 2018

1 reference

A review of the S100 proteins in cancer

21 January 2018

1 reference

Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations

21 January 2018

1 reference

Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells

21 January 2018

1 reference

S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells

21 January 2018

1 reference

Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma

21 January 2018

1 reference

Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers.

21 January 2018

1 reference

Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma

21 January 2018

1 reference

Estrogens Promote Invasion of Prostate Cancer Cells in a Paracrine Manner through Up-Regulation of Matrix Metalloproteinase 2 in Prostatic Stromal Cells

21 January 2018

1 reference

A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression

21 January 2018

1 reference

Lack of an endogenous anti-inflammatory protein in mice enhances colonization of B16F10 melanoma cells in the lungs.

21 January 2018

1 reference

Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions.

21 January 2018

1 reference

A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27764

1 reference

10 September 2017

1 reference